We are currently unable to supply Varenicline, a Stop Smoking medication. However, we are working towards making it available early next year.

Notification

information

We are currently unable to supply Varenicline, the Stop Smoking medication recently mentioned in the news. However, we are working towards making it available early next year. Previously known as Champix, Varenicline was withdrawn from the market in June 2021 due to manufacturing impurities. It is now being produced by a different company and will be offered once supply processes are completed.

Introduction

Some people find nicotine cravings the hardest thing to cope with when quitting. There are plenty of Nicotine Replacement Therapy (NRT) products out there and they can give you the extra support you need to beat the cravings. Using licensed stop-smoking medications, in combination with support from your local stop-smoking service, means you are four times more likely to stay quit.

How stop smoking medications work

Cigarettes contain nicotine. By smoking regularly and over a long period of time, your body becomes dependent on nicotine. Giving up smoking can cause nicotine withdrawal symptoms, which include cravings, headaches, feeling irritable and not being able to sleep. Stop smoking medicines can help you manage these withdrawal symptoms.

Nicotine Replacement Therapy (NRT) including patches, gum, lozenges, inhalator and mouth spray are all available from the service and can also be bought from pharmacies without a prescription and other shops (such as supermarkets).

All are effective treatments to help you stop smoking, but you may find one suits you more than another. There are lots of things to consider, so we recommend that you speak to one of our specialist Stop Smoking Practitioners.

Book an Appointment

If you would like to access support please complete our booking form below and we will be in contact as soon as possible to discuss how we can support you with stopping smoking.

Last reviewed: November 13, 2024 by Adam

Next review due: May 13, 2025

Back to top